{"id":"https://openalex.org/W2011209243","doi":"https://doi.org/10.1097/00004872-200403000-00029","title":"Development of diabetes is retarded by ACE inhibition in hypertensive patients ??? a subanalysis of the Captopril Prevention Project (CAPPP)","display_name":"Development of diabetes is retarded by ACE inhibition in hypertensive patients ??? a subanalysis of the Captopril Prevention Project (CAPPP)","alternate_titles":[],"publication_year":2004,"publication_date":"2004-03-01","ids":{"openalex":"https://openalex.org/W2011209243","doi":"https://doi.org/10.1097/00004872-200403000-00029","mag":"2011209243","pmid":"https://pubmed.ncbi.nlm.nih.gov/15076172"},"language":"en","primary_location":{"id":"doi:10.1097/00004872-200403000-00029","doi":"https://doi.org/10.1097/00004872-200403000-00029","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004872-200403000-00029","pdf_url":null,"source":{"id":"https://openalex.org/S115964404","display_name":"Journal of Hypertension","issn_l":"0263-6352","issn":["0263-6352","1473-5598"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hypertension","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2011209243"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005138389","display_name":"Anders Niklason","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I881427289","display_name":"University of Gothenburg","ror":"https://ror.org/01tm6cn81","country_code":"SE","type":"education","lineage":["https://openalex.org/I881427289"]}],"countries":["SE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Anders Niklason","raw_affiliation_strings":["Department of Clinical Pharmacology, Sahlgrenska Academy at G\u00f6teborg University, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Sahlgrenska Academy at G\u00f6teborg University, Sweden","institution_ids":["https://openalex.org/I881427289"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108082242","display_name":"Thomas Hedner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I881427289","display_name":"University of Gothenburg","ror":"https://ror.org/01tm6cn81","country_code":"SE","type":"education","lineage":["https://openalex.org/I881427289"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thomas Hedner","raw_affiliation_strings":["Department of Clinical Pharmacology, the Sahlgrenska Academy at G\u00f6teborg University, G\u00f6teborg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, the Sahlgrenska Academy at G\u00f6teborg University, G\u00f6teborg, Sweden","institution_ids":["https://openalex.org/I881427289"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048168425","display_name":"LEO K. NISKANEN","orcid":"https://orcid.org/0000-0003-1503-7060","observed_orcids":["https://orcid.org/0000-0003-1503-7060"]},"institutions":[{"id":"https://openalex.org/I4210092991","display_name":"Kuopio University Hospital","ror":"https://ror.org/00fqdfs68","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I4210092991","https://openalex.org/I4405278559"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Leo Niskanen","raw_affiliation_strings":["Department of Medicine, Kuopio University Hospital, Kuopio, Finland and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Kuopio University Hospital, Kuopio, Finland and","institution_ids":["https://openalex.org/I4210092991"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033274789","display_name":"Jan Lanke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]},{"id":"https://openalex.org/I2801112325","display_name":"Sahlgrenska University Hospital","ror":"https://ror.org/04vgqjj36","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I2801112325"]},{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["SE","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jan Lanke","raw_affiliation_strings":["Conflicts of interest: At the time of the study, the steering committee, as well as the individual investigators, received individual research as well as travelling support from Bristol-Myers Squibb in order to conduct the CAPPP trial. Since 1999, and in relation to the present analyses, no such individual support has been provided to any of the authors (A.N., T.H., L.N., J.L.), or to the CAPPP study group","Department of Statistics, Lund University, Lund, Sweden","See editorial commentary on page 463","Sponsorship: This study was supported by grants from LUA Sahlgrenska University Hospital G\u00f6teborg and from \u2018V\u00e4stra G\u00f6talandsRegionen', Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Conflicts of interest: At the time of the study, the steering committee, as well as the individual investigators, received individual research as well as travelling support from Bristol-Myers Squibb in order to conduct the CAPPP trial. Since 1999, and in relation to the present analyses, no such individual support has been provided to any of the authors (A.N., T.H., L.N., J.L.), or to the CAPPP study group","institution_ids":["https://openalex.org/I4210091812"]},{"raw_affiliation_string":"Department of Statistics, Lund University, Lund, Sweden","institution_ids":["https://openalex.org/I187531555"]},{"raw_affiliation_string":"See editorial commentary on page 463","institution_ids":[]},{"raw_affiliation_string":"Sponsorship: This study was supported by grants from LUA Sahlgrenska University Hospital G\u00f6teborg and from \u2018V\u00e4stra G\u00f6talandsRegionen', Sweden","institution_ids":["https://openalex.org/I2801112325"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5005138389"],"corresponding_institution_ids":["https://openalex.org/I881427289"],"apc_list":null,"apc_paid":null,"fwci":8.7015,"has_fulltext":false,"cited_by_count":106,"citation_normalized_percentile":{"value":0.98091228,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"22","issue":"3","first_page":"645","last_page":"652"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9789999723434448,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9789999723434448,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.009800000116229057,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.00559999980032444,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/captopril","display_name":"captopril","score":0.8159999847412109},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.7350000143051147},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.7509999871253967},{"id":"https://openalex.org/keywords/diabetes-prevention","display_name":"diabetes prevention","score":0.8399999737739563},{"id":"https://openalex.org/keywords/diabetes-risk-factors","display_name":"diabetes risk factors","score":0.8259999752044678},{"id":"https://openalex.org/keywords/risk-score","display_name":"risk score","score":0.6209999918937683},{"id":"https://openalex.org/keywords/diuretics","display_name":"diuretics","score":0.6129999756813049},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antihypertensive-therapy","display_name":"antihypertensive therapy","score":0.7710000276565552},{"id":"https://openalex.org/keywords/body-mass-index","display_name":"body mass index","score":0.6480000019073486},{"id":"https://openalex.org/keywords/hemoglobin","display_name":"hemoglobin","score":0.8050000071525574},{"id":"https://openalex.org/keywords/blood-glucose","display_name":"blood glucose","score":0.4950000047683716}],"concepts":[{"id":"https://openalex.org/C2779479957","wikidata":"https://www.wikidata.org/wiki/Q421119","display_name":"Captopril","level":3,"score":0.9613913297653198},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9391661882400513},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.7478852272033691},{"id":"https://openalex.org/C2779918671","wikidata":"https://www.wikidata.org/wiki/Q200656","display_name":"Diuretic","level":2,"score":0.6602046489715576},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6519473791122437},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5684354305267334},{"id":"https://openalex.org/C2780221984","wikidata":"https://www.wikidata.org/wiki/Q131191","display_name":"Body mass index","level":2,"score":0.55314701795578},{"id":"https://openalex.org/C2779611605","wikidata":"https://www.wikidata.org/wiki/Q288280","display_name":"ACE inhibitor","level":4,"score":0.5362960696220398},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5241725444793701},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.44066742062568665},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.4344256818294525},{"id":"https://openalex.org/C27016395","wikidata":"https://www.wikidata.org/wiki/Q128861","display_name":"Angiotensin-converting enzyme","level":3,"score":0.38711637258529663},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.363203227519989},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3390125036239624},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.2811867594718933}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002216","descriptor_name":"Captopril","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015999","descriptor_name":"Multivariate Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1097/00004872-200403000-00029","doi":"https://doi.org/10.1097/00004872-200403000-00029","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004872-200403000-00029","pdf_url":null,"source":{"id":"https://openalex.org/S115964404","display_name":"Journal of Hypertension","issn_l":"0263-6352","issn":["0263-6352","1473-5598"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hypertension","raw_type":"journal-article"},{"id":"pmid:15076172","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15076172","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of hypertension","raw_type":"Clinical Trial"},{"id":"pmh:oai:lup.lub.lu.se:df17b347-1f79-4ffe-add0-21ea32baa245","doi":null,"is_oa":false,"landing_page_url":"https://lup.lub.lu.se/record/281818","pdf_url":null,"source":{"id":"https://openalex.org/S4306400536","display_name":"Lund University Publications (Lund University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I187531555","host_organization_name":"Lund University","host_organization_lineage":["https://openalex.org/I187531555"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ISSN: 1473-5598","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:2011209243","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15076172","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W180946569","https://openalex.org/W1604542334","https://openalex.org/W1974548284","https://openalex.org/W1982920623","https://openalex.org/W2018791545","https://openalex.org/W2025862646","https://openalex.org/W2036266922","https://openalex.org/W2048155592","https://openalex.org/W2059537042","https://openalex.org/W2061873243","https://openalex.org/W2102979143","https://openalex.org/W2112122483","https://openalex.org/W2121664713","https://openalex.org/W2122741041","https://openalex.org/W2133217116","https://openalex.org/W2159844688","https://openalex.org/W2165141146","https://openalex.org/W2167585986","https://openalex.org/W4238603304","https://openalex.org/W4254338243"],"related_works":["https://openalex.org/W2112122483","https://openalex.org/W2059153986","https://openalex.org/W2166423858","https://openalex.org/W4240338945","https://openalex.org/W91417355","https://openalex.org/W2076697052","https://openalex.org/W1964229485","https://openalex.org/W2332644784","https://openalex.org/W2511592591","https://openalex.org/W2400210637"],"abstract_inverted_index":{"OBJECTIVE:":[0],"The":[1],"Captopril":[2],"Prevention":[3],"Project":[4],"(CAPPP)":[5],"was":[6,41,61,69,153,171,191],"designed":[7],"as":[8,76,78,139,224],"a":[9,17,30,146,174,240],"prospective":[10],"intervention":[11],"trial":[12],"comparing":[13],"the":[14,21,45,64,100,188,206],"effect":[15],"of":[16,29,55,96,102,151,167,177,243],"treatment":[18,60,136,235],"based":[19,250],"on":[20,143,251],"angiotensin-converting":[22],"enzyme":[23],"(ACE)":[24],"inhibitor":[25],"captopril":[26,59,169],"with":[27,99,173,181,239,247],"that":[28,68,83,108,205],"conventional":[31,182,248],"diuretic":[32,183],"and/or":[33,184,253],"beta-blocker-based":[34],"therapy,":[35],"in":[36,44,63,79,105,227],"10,985":[37],"hypertensive":[38],"patients.":[39],"There":[40],"no":[42],"difference":[43],"primary":[46],"cardiovascular":[47],"morbidity":[48],"and":[49,128,133,198,220],"mortality":[50],"endpoint.":[51],"A":[52,93,232],"lower":[53,241],"incidence":[54],"diabetes":[56,104,152,178,211,244],"mellitus":[57],"during":[58],"observed":[62],"whole":[65],"CAPPP":[66,81,106],"cohort":[67,190],"non-diabetic":[70,157,189],"at":[71,126],"baseline":[72,127],"(n":[73,87],"=":[74,88],"10,413)":[75],"well":[77],"such":[80],"patients":[82],"were":[84,160],"previously":[85,196,199],"untreated":[86,200],"5033).":[89],"METHODS":[90],"AND":[91],"RESULTS:":[92],"multivariate":[94],"analysis":[95],"variables":[97],"associated":[98,172,238],"risk":[101,140,147,176,207,225,242],"developing":[103,210],"demonstrated":[107],"glucose,":[109,218],"body":[110],"mass":[111],"index":[112],"(BMI),":[113],"haemoglobin":[114],"(Hb),":[115],"age,":[116],"'SBP":[117],"x":[118],"Untreated'":[119],"(the":[120],"interaction":[121],"between":[122,213],"systolic":[123],"blood":[124],"pressure":[125],"newly":[129],"diagnosed":[130],"hypertension),":[131],"cholesterol":[132],"prior":[134],"antihypertensive":[135,234],"came":[137,222],"out":[138,204,223],"factors.":[141],"Based":[142],"these":[144,214],"factors,":[145],"score":[148],"for":[149,155,209],"development":[150,179],"calculated":[154],"all":[156,228],"patients,":[158,201],"who":[159],"divided":[161,192],"into":[162,193],"tertiles.":[163],"For":[164],"each":[165],"tertile":[166],"risk,":[168],"therapy":[170,249],"reduced":[175],"compared":[180,246],"beta-blocker":[185],"therapy.":[186],"When":[187],"two":[194,215],"subcohorts;":[195],"treated":[197],"it":[202],"turned":[203],"factors":[208,226],"differed":[212],"subcohorts.":[216],"Only":[217],"BMI":[219],"Hb":[221],"analysed":[229],"cohorts.":[230],"CONCLUSION:":[231],"captopril-based":[233],"regimen":[236],"is":[237],"development,":[245],"diuretics":[252],"beta-blockers.":[254]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2011209243","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
